Journal Browser Advanced Search Help
Journal Browser Advanced search HELP
J Rheum Dis. 2017 Apr;24(2):114-118. English. Case Report. https://doi.org/10.4078/jrd.2017.24.2.114
Yoon SY , Yoo ES , Yoo EJ , Jung JY , Kim HA , Suh CH .
Department of Rheumatology, Ajou University School of Medicine, Suwon, Korea. chsuh@aumc.ac.kr
Abstract

Pulmonary arterial hypertension is a critical manifestation of systemic sclerosis (SSc) and is a main cause of death. Several treatment modalities for SSc have been identified, with effects that improve quality of life and mortality rates. However, whether these drugs can also normalize pulmonary arterial pressure, remains unclear. Here, we report the case of a woman with diffuse SSc with pulmonary arterial hypertension, who had a functional status equivalent to the New York Heart Association class III. The patient was treated with inhaled iloprost. After six years of inhaled iloprost therapy, echocardiography showed that pulmonary arterial pressure normalized, accompanied by improvement in functional capacity. Inhaled iloprost might not only normalize pulmonary arterial pressure, but also improve the functional status of patients with SSc with pulmonary arterial hypertension.

Copyright © 2019. Korean Association of Medical Journal Editors.